Papers
6
Total Citations
410
H-Index
5
About
Joaquim Bellmunt is a leading oncologist whose research has fundamentally shaped the management of genitourinary cancers, with a particular focus on bladder cancer. His major contributions lie in the comparative effectiveness and health economics of surgical treatments for muscle-invasive bladder cancer. Bellmunt’s landmark 2014 study, a propensity-matched analysis of over 2,300 patients, demonstrated that robot-assisted radical cystectomy offers comparable morbidity but significantly higher costs than open surgery—a finding cited over 235 times and crucial for evidence-based surgical decision-making. He further explored these cost variations across U.S. hospitals and, in a multicenter study, evaluated outcomes for patients receiving perioperative chemotherapy, providing the oncologist’s perspective on surgical approaches. With cumulative citations exceeding 400, Bellmunt’s work has been instrumental in advancing value-based care in urologic oncology. He has also contributed to broader discussions on optimizing treatment continua for genitourinary cancers, as highlighted by his participation in the Interactive Genitourinary Cancer Conference. Through rigorous population-based analyses, Bellmunt has empowered clinicians and policymakers to weigh the trade-offs between surgical innovation and economic sustainability, making him a pivotal figure in modern bladder cancer care.
Research Focus
Key Achievements
Top Papers
- 1
- 2Variations in the Costs of Radical Cystectomy for Bladder Cancer in the USA83 citations · 2017
- 3Comparative effectiveness of robot-assisted vs. open radical cystectomy75 citations · 2017
- 4
- 5
- 6